These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28248125)

  • 1. Drug delivery via porous silicon: a focused patent review.
    Kulyavtsev PA; Spencer RP
    Pharm Pat Anal; 2017 Mar; 6(2):77-85. PubMed ID: 28248125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silicon-polymer hybrid materials for drug delivery.
    McInnes SJ; Voelcker NH
    Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silicon in drug delivery applications.
    Salonen J; Kaukonen AM; Hirvonen J; Lehto VP
    J Pharm Sci; 2008 Feb; 97(2):632-53. PubMed ID: 17546667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured porous silicon-polymer-based hybrids: from biosensing to drug delivery.
    Bonanno LM; Segal E
    Nanomedicine (Lond); 2011 Dec; 6(10):1755-70. PubMed ID: 22122584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured porous silicon-mediated drug delivery.
    Martín-Palma RJ; Hernández-Montelongo J; Torres-Costa V; Manso-Silván M; Muñoz-Noval Á
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1273-83. PubMed ID: 24941438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional porous silicon for therapeutic drug delivery and imaging.
    Santos HA; Bimbo LM; Lehto VP; Airaksinen AJ; Salonen J; Hirvonen J
    Curr Drug Discov Technol; 2011 Sep; 8(3):228-49. PubMed ID: 21291407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silicon: a platform for the delivery of therapeutics.
    Prestidge CA; Barnes TJ; Lau CH; Barnett C; Loni A; Canham L
    Expert Opin Drug Deliv; 2007 Mar; 4(2):101-10. PubMed ID: 17335408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
    Giret S; Wong Chi Man M; Carcel C
    Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery from ordered mesoporous matrices.
    Manzano M; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1383-400. PubMed ID: 19941412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionalized mesoporous silica materials for controlled drug delivery.
    Yang P; Gai S; Lin J
    Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
    Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Missing Tooth" Multidomain Peptide Nanofibers for Delivery of Small Molecule Drugs.
    Li IC; Moore AN; Hartgerink JD
    Biomacromolecules; 2016 Jun; 17(6):2087-95. PubMed ID: 27253735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothermic Reduction of Silica Nanoparticles to Porous Silicon for Drug Delivery Using New and Existing Reductants.
    Lai Y; Thompson JR; Dasog M
    Chemistry; 2018 Jun; 24(31):7913-7920. PubMed ID: 29569356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering silica particles as oral drug delivery vehicles.
    Rigby SP; Fairhead M; van der Walle CF
    Curr Pharm Des; 2008; 14(18):1821-31. PubMed ID: 18673185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradation of inorganic drug delivery systems in subcutaneous conditions.
    Kovalainen M; Kamakura R; Riikonen J; Finnilä M; Nissinen T; Rantanen J; Niemelä M; Perämäki P; Mäkinen M; Herzig KH; Lehto VP
    Eur J Pharm Biopharm; 2018 Jan; 122():113-125. PubMed ID: 29056485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks.
    Baeza A; Ruiz-Molina D; Vallet-Regí M
    Expert Opin Drug Deliv; 2017 Jun; 14(6):783-796. PubMed ID: 27575454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent patents on the synthesis and application of silica nanoparticles for drug delivery.
    Foglia ML; Alvarez GS; Catalano PN; Mebert AM; Diaz LE; Coradin T; Desimone MF
    Recent Pat Biotechnol; 2011 Apr; 5(1):54-61. PubMed ID: 21517744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
    Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
    Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous systems for poorly soluble drugs.
    Xu W; Riikonen J; Lehto VP
    Int J Pharm; 2013 Aug; 453(1):181-97. PubMed ID: 22990124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature responsive porous silicon nanoparticles for cancer therapy - spatiotemporal triggering through infrared and radiofrequency electromagnetic heating.
    Tamarov K; Xu W; Osminkina L; Zinovyev S; Soininen P; Kudryavtsev A; Gongalsky M; Gaydarova A; Närvänen A; Timoshenko V; Lehto VP
    J Control Release; 2016 Nov; 241():220-228. PubMed ID: 27686581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.